WallStreetZenWallStreetZen

NASDAQ: AADI
Aadi Bioscience Inc Stock

$1.69+0.01 (+0.6%)
Updated Jun 14, 2024
AADI Price
$1.69
Fair Value Price
N/A
Market Cap
$41.50M
52 Week Low
$1.55
52 Week High
$8.20
P/E
-0.66x
P/B
0.46x
P/S
2.65x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.84M
Earnings
-$68.83M
Gross Margin
87.7%
Operating Margin
-287.75%
Profit Margin
-288.7%
Debt to Equity
0.23
Operating Cash Flow
-$58M
Beta
0.6
Next Earnings
Aug 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AADI Overview

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AADI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AADI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AADI is good value based on its book value relative to its share price (0.46x), compared to the US Biotechnology industry average (6.25x)
P/B vs Industry Valuation
AADI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AADI due diligence checks available for Premium users.

Be the first to know about important AADI news, forecast changes, insider trades & much more!

AADI News

Valuation

AADI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.66x
Industry
-10.23x
Market
30.51x

AADI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.46x
Industry
6.25x
AADI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AADI's financial health

Profit margin

Revenue
$5.4M
Net Income
-$18.3M
Profit Margin
-341.7%
AADI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AADI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$111.1M
Liabilities
$20.6M
Debt to equity
0.23
AADI's short-term assets ($102.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AADI's short-term assets ($102.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AADI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AADI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$19.7M
Investing
$10.6M
Financing
-$10.0k
AADI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AADI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AADI$41.50M+0.60%-0.66x0.46x
CTCX$41.40M-0.50%N/A-29.75x
CASI$41.61M-4.60%-1.54x1.72x
MLEC$41.32M+3.77%-8.46x6.18x
RVPH$40.76M-2.67%-0.92x-30.29x

Aadi Bioscience Stock FAQ

What is Aadi Bioscience's quote symbol?

(NASDAQ: AADI) Aadi Bioscience trades on the NASDAQ under the ticker symbol AADI. Aadi Bioscience stock quotes can also be displayed as NASDAQ: AADI.

If you're new to stock investing, here's how to buy Aadi Bioscience stock.

What is the 52 week high and low for Aadi Bioscience (NASDAQ: AADI)?

(NASDAQ: AADI) Aadi Bioscience's 52-week high was $8.20, and its 52-week low was $1.55. It is currently -79.39% from its 52-week high and 9.03% from its 52-week low.

How much is Aadi Bioscience stock worth today?

(NASDAQ: AADI) Aadi Bioscience currently has 24,554,205 outstanding shares. With Aadi Bioscience stock trading at $1.69 per share, the total value of Aadi Bioscience stock (market capitalization) is $41.50M.

Aadi Bioscience stock was originally listed at a price of $90.00 in Aug 9, 2017. If you had invested in Aadi Bioscience stock at $90.00, your return over the last 6 years would have been -98.12%, for an annualized return of -48.44% (not including any dividends or dividend reinvestments).

How much is Aadi Bioscience's stock price per share?

(NASDAQ: AADI) Aadi Bioscience stock price per share is $1.69 today (as of Jun 14, 2024).

What is Aadi Bioscience's Market Cap?

(NASDAQ: AADI) Aadi Bioscience's market cap is $41.50M, as of Jun 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aadi Bioscience's market cap is calculated by multiplying AADI's current stock price of $1.69 by AADI's total outstanding shares of 24,554,205.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.